|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.01 HKD | -0.73% |
|
+0.94% | -19.60% |
| 06:24am | Nomura Adjusts Li Ning's Price Target to HK$16 From HK$23.40, Keeps at Neutral | MT |
| 07-15 | Li Ning's Retail Sell-Through Down in Q2 | MT |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 13.99 | 9.17 | 6.4 | 7.06 | 7.01 | |||||
Return on Total Capital | 19.52 | 11.99 | 8.13 | 8.98 | 8.91 | |||||
Return On Equity % | 26.92 | 17.89 | 13.08 | 11.93 | 10.93 | |||||
Return on Common Equity | 26.93 | 17.89 | 13.08 | 11.93 | 10.93 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 53.03 | 48.38 | 48.38 | 49.37 | 48.95 | |||||
SG&A Margin | 32.1 | 32.66 | 37.45 | 37.06 | 36.56 | |||||
EBITDA Margin % | 25.16 | 21.33 | 16.57 | 17.97 | 16.72 | |||||
EBITA Margin % | 22.33 | 18.26 | 12.66 | 13.85 | 13.99 | |||||
EBIT Margin % | 22.25 | 18.18 | 12.59 | 13.77 | 13.91 | |||||
Income From Continuing Operations Margin % | 17.77 | 15.75 | 11.55 | 10.51 | 9.92 | |||||
Net Income Margin % | 17.77 | 15.75 | 11.55 | 10.51 | 9.92 | |||||
Net Avail. For Common Margin % | 17.77 | 15.75 | 11.55 | 10.51 | 9.92 | |||||
Normalized Net Income Margin | 14.43 | 12.65 | 9.45 | 9.56 | 9.3 | |||||
Levered Free Cash Flow Margin | 18.67 | 3.24 | 6.41 | 11.29 | 9.18 | |||||
Unlevered Free Cash Flow Margin | 18.85 | 3.49 | 6.77 | 11.62 | 9.45 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 1.01 | 0.81 | 0.81 | 0.82 | 0.81 | |||||
Fixed Assets Turnover | 8.87 | 6.28 | 4.77 | 4.59 | 4.73 | |||||
Receivables Turnover (Average Receivables) | 28.91 | 26.83 | 24.8 | 25.95 | 24.73 | |||||
Inventory Turnover (Average Inventory) | 6.8 | 6.34 | 5.79 | 5.7 | 5.71 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 2.42 | 1.71 | 1.88 | 2.71 | 2.85 | |||||
Quick Ratio | 2.09 | 1.33 | 1.48 | 2.31 | 2.41 | |||||
Operating Cash Flow to Current Liabilities | 0.85 | 0.54 | 0.64 | 0.69 | 0.6 | |||||
Days Sales Outstanding (Average Receivables) | 12.63 | 13.6 | 14.72 | 14.1 | 14.76 | |||||
Days Outstanding Inventory (Average Inventory) | 53.67 | 57.56 | 63.04 | 64.17 | 63.92 | |||||
Average Days Payable Outstanding | 46.76 | 41.58 | 43.03 | 42.73 | 42.33 | |||||
Cash Conversion Cycle (Average Days) | 19.54 | 29.59 | 34.73 | 35.54 | 36.35 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 6.27 | 8.8 | 10.42 | 7.42 | 7.44 | |||||
Total Debt / Total Capital | 5.9 | 8.09 | 9.43 | 6.9 | 6.92 | |||||
LT Debt/Equity | 4.53 | 6.06 | 7.48 | 5.3 | 5.3 | |||||
Long-Term Debt / Total Capital | 4.26 | 5.57 | 6.77 | 4.94 | 4.94 | |||||
Total Liabilities / Total Assets | 30.29 | 27.68 | 28.65 | 26.9 | 26.74 | |||||
EBIT / Interest Expense | 77.93 | 45.8 | 21.65 | 25.46 | 31.95 | |||||
EBITDA / Interest Expense | 95.28 | 59.71 | 33.24 | 37.16 | 42.29 | |||||
(EBITDA - Capex) / Interest Expense | 67.96 | 39.75 | 21.23 | 27.94 | 32.8 | |||||
Total Debt / EBITDA | 0.22 | 0.35 | 0.48 | 0.34 | 0.38 | |||||
Net Debt / EBITDA | -2.25 | -0.96 | -1.2 | -2.4 | -2.89 | |||||
Total Debt / (EBITDA - Capex) | 0.3 | 0.53 | 0.75 | 0.45 | 0.49 | |||||
Net Debt / (EBITDA - Capex) | -3.16 | -1.45 | -1.88 | -3.19 | -3.73 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 56.13 | 14.31 | 6.96 | 3.9 | 3.22 | |||||
Gross Profit, 1 Yr. Growth % | 68.71 | 4.31 | 6.95 | 6.02 | 2.35 | |||||
EBITDA, 1 Yr. Growth % | 114.75 | -3.07 | -16.92 | 12.69 | -3.94 | |||||
EBITA, 1 Yr. Growth % | 139.28 | -6.53 | -25.85 | 13.69 | 4.26 | |||||
EBIT, 1 Yr. Growth % | 140.81 | -6.6 | -25.93 | 13.67 | 4.21 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 136.15 | 1.32 | -21.58 | -5.46 | -2.56 | |||||
Net Income, 1 Yr. Growth % | 136.14 | 1.32 | -21.58 | -5.46 | -2.56 | |||||
Normalized Net Income, 1 Yr. Growth % | 143.58 | 0.2 | -20.11 | 5.13 | 0.46 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 133.61 | -2.3 | -20.53 | -5.01 | -2.57 | |||||
Accounts Receivable, 1 Yr. Growth % | 37.05 | 13.01 | 18.15 | -16.67 | 38.23 | |||||
Inventory, 1 Yr. Growth % | 31.75 | 36.96 | 2.68 | 4.21 | 3.68 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 38.84 | 77.68 | 20 | -1.92 | 2.07 | |||||
Total Assets, 1 Yr. Growth % | 107.45 | 11.14 | 1.67 | 4.39 | 5.62 | |||||
Tangible Book Value, 1 Yr. Growth % | 149.12 | 15.43 | 0.32 | 7.02 | 6.24 | |||||
Common Equity, 1 Yr. Growth % | 142.91 | 15.3 | 0.32 | 6.95 | 5.84 | |||||
Cash From Operations, 1 Yr. Growth % | 136.14 | -40.02 | 19.79 | 12.37 | -7.9 | |||||
Capital Expenditures, 1 Yr. Growth % | 196.4 | 16.13 | -5.73 | -25.76 | -14.57 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 124.19 | -80.17 | 111.63 | 82.97 | -16.04 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 122.35 | -78.85 | 107.72 | 78.34 | -16.09 | |||||
Dividend Per Share, 1 Yr. Growth % | 124.68 | 0.65 | 18.31 | 6.83 | -2.62 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 27.57 | 33.6 | 10.57 | 5.42 | 3.56 | |||||
Gross Profit, 2 Yr. CAGR % | 32.62 | 32.66 | 5.62 | 6.48 | 4.17 | |||||
EBITDA, 2 Yr. CAGR % | 71.62 | 44.27 | -10.26 | -3.24 | 4.04 | |||||
EBITA, 2 Yr. CAGR % | 82.81 | 49.55 | -16.75 | -8.18 | 8.87 | |||||
EBIT, 2 Yr. CAGR % | 83.65 | 49.97 | -16.82 | -8.24 | 8.84 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 63.57 | 54.68 | -10.86 | -13.89 | -4.02 | |||||
Net Income, 2 Yr. CAGR % | 63.57 | 54.68 | -10.86 | -13.9 | -4.02 | |||||
Normalized Net Income, 2 Yr. CAGR % | 66.44 | 56.23 | -10.53 | -8.36 | 2.77 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 62.08 | 51.08 | -11.88 | -13.11 | -3.79 | |||||
Accounts Receivable, 2 Yr. CAGR % | 14.67 | 24.45 | 15.55 | -0.78 | 7.33 | |||||
Inventory, 2 Yr. CAGR % | 12.24 | 34.33 | 18.59 | 3.45 | 3.94 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 21.02 | 57.06 | 46.02 | 8.49 | 0.06 | |||||
Total Assets, 2 Yr. CAGR % | 55.33 | 51.84 | 6.3 | 3.02 | 5 | |||||
Tangible Book Value, 2 Yr. CAGR % | 73.97 | 69.58 | 7.61 | 3.62 | 6.63 | |||||
Common Equity, 2 Yr. CAGR % | 72.13 | 67.35 | 7.55 | 3.58 | 6.39 | |||||
Cash From Operations, 2 Yr. CAGR % | 36.47 | 19.01 | -15.24 | 16.02 | 1.73 | |||||
Capital Expenditures, 2 Yr. CAGR % | 66.38 | 85.53 | 4.63 | -16.34 | -20.36 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 20.53 | -33.32 | -35.22 | 96.78 | 23.92 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 20.51 | -31.43 | -33.72 | 92.47 | 22.33 | |||||
Dividend Per Share, 2 Yr. CAGR % | 72.38 | 50.38 | 9.12 | 12.42 | 2 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 29.02 | 22.99 | 24.05 | 8.3 | 4.68 | |||||
Gross Profit, 3 Yr. CAGR % | 33.3 | 22.42 | 23.47 | 5.75 | 5.09 | |||||
EBITDA, 3 Yr. CAGR % | 72.99 | 41.86 | 20.03 | -3.19 | -3.48 | |||||
EBITA, 3 Yr. CAGR % | 90.08 | 46.18 | 18.37 | -7.64 | -4.21 | |||||
EBIT, 3 Yr. CAGR % | 92.29 | 46.59 | 18.55 | -7.7 | -4.27 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 77.66 | 39.43 | 23.34 | -9.1 | -10.27 | |||||
Net Income, 3 Yr. CAGR % | 77.66 | 39.43 | 23.34 | -9.1 | -10.27 | |||||
Normalized Net Income, 3 Yr. CAGR % | 84.31 | 40.54 | 24.93 | -5.59 | -5.51 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 75.57 | 36.92 | 21.96 | -9.65 | -9.73 | |||||
Accounts Receivable, 3 Yr. CAGR % | -0.94 | 14.12 | 22.31 | 3.62 | 10.82 | |||||
Inventory, 3 Yr. CAGR % | 12.66 | 19.94 | 22.83 | 13.59 | 3.52 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 52.75 | 37.55 | 43.58 | 27.88 | 6.31 | |||||
Total Assets, 3 Yr. CAGR % | 51.38 | 38.93 | 32.84 | 5.66 | 3.88 | |||||
Tangible Book Value, 3 Yr. CAGR % | 55.59 | 51.74 | 42.36 | 7.41 | 4.49 | |||||
Common Equity, 3 Yr. CAGR % | 53.65 | 50.61 | 41.11 | 7.35 | 4.33 | |||||
Cash From Operations, 3 Yr. CAGR % | 57.45 | 3.76 | 19.27 | -6.89 | 7.42 | |||||
Capital Expenditures, 3 Yr. CAGR % | 46.79 | 47.59 | 48.04 | -6.68 | -15.76 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 69.47 | -33.96 | -2.01 | -8.43 | 48.12 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 70.01 | -32.53 | -0.78 | -7.82 | 45.94 | |||||
Dividend Per Share, 3 Yr. CAGR % | 73.64 | 44.08 | 38.82 | 8.35 | 7.17 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 23.01 | 23.8 | 21.3 | 15.64 | 15.41 | |||||
Gross Profit, 5 Yr. CAGR % | 26.43 | 24.48 | 21.45 | 15.78 | 15.35 | |||||
EBITDA, 5 Yr. CAGR % | 52.92 | 47.65 | 33.05 | 21.73 | 13.36 | |||||
EBITA, 5 Yr. CAGR % | 65.24 | 59.09 | 36.62 | 21.37 | 14.48 | |||||
EBIT, 5 Yr. CAGR % | 67.2 | 60.92 | 37.52 | 21.54 | 14.56 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 73.45 | 51.15 | 34.83 | 14.98 | 11.57 | |||||
Net Income, 5 Yr. CAGR % | 44.2 | 51.15 | 34.83 | 14.98 | 11.57 | |||||
Normalized Net Income, 5 Yr. CAGR % | 78.63 | 58.9 | 38.04 | 18.45 | 15.54 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 68.88 | 49.21 | 33.26 | 14.15 | 10.92 | |||||
Accounts Receivable, 5 Yr. CAGR % | -8.01 | -2.16 | 5.35 | 7.91 | 16.08 | |||||
Inventory, 5 Yr. CAGR % | 12.92 | 17.1 | 15 | 13.05 | 14.89 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 29.02 | 44.37 | 50.02 | 25.09 | 24.27 | |||||
Total Assets, 5 Yr. CAGR % | 34.89 | 35.67 | 31.42 | 23.27 | 20.91 | |||||
Tangible Book Value, 5 Yr. CAGR % | 41.69 | 38.28 | 34.26 | 30.27 | 26.82 | |||||
Common Equity, 5 Yr. CAGR % | 39.5 | 36.84 | 33.22 | 29.67 | 26.04 | |||||
Cash From Operations, 5 Yr. CAGR % | 45.65 | 27.55 | 22.9 | 8.5 | 11.92 | |||||
Capital Expenditures, 5 Yr. CAGR % | 35.68 | 39.33 | 28.2 | 17.61 | 15.53 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 37.63 | 7.83 | 15.36 | 2.21 | 7.64 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 36.42 | 9.17 | 16.64 | 2.61 | 7.88 | |||||
Dividend Per Share, 5 Yr. CAGR % | - | - | 44.2 | 30.47 | 22.72 |
- Stock Market
- Stocks
- 2331 Stock
- Financials Li Ning Company Limited
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















